Clinical Trial Update: Comparison of DisCoVisc and Hydroxypropylmethylcellulose 2% [Phase 4]

View source ↗

Summary

Phase 4 trial comparing DisCoVisc with Hydroxypropylmethylcellulose 2% for corneal edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Edema

Drugs mentioned

• DisCoVisc
• Hydroxypropylmethylcellulose 2% (Hydroxypropylmethylcellulose)

Snippet

Sponsor: University of Sao Paulo | Conditions: Corneal Edema, Intraocular Pressure | Phase 4 | Status: COMPLETED